Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain

M. H. Tuszynski, U. Hoi Sang, Kazunari Yoshida, F. H. Gage

Research output: Contribution to journalArticle

167 Citations (Scopus)

Abstract

Atrophy of cholinergic neurons is a prominent component of Alzheimer's disease, and may explain in part the profound memory loss that is characteristic of patients with this disorder. Previous studies in animal models have shown that infusions of nerve growth factor into the adult brain can prevent both age-related and lesion-induced cholinergic neuronal atrophy. Recently, recombinant human nerve growth factor was found biologically active in nonprimate animal models. In the present experiment, recombinant human nerve growth factor infusions into the brains of adult primates prevented lesion-induced cholinergic neuronal degeneration and promoted cholinergic neurite sprouting. These findings provide additional support for potential therapeutic trials of human nerve growth factor in patients with Alzheimer's disease.

Original languageEnglish
Pages (from-to)625-636
Number of pages12
JournalAnnals of Neurology
Volume30
Issue number5
Publication statusPublished - 1991
Externally publishedYes

Fingerprint

Nerve Growth Factor
Cholinergic Agents
Primates
Brain
Atrophy
Alzheimer Disease
Animal Models
Cholinergic Neurons
Memory Disorders
Neurites
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. / Tuszynski, M. H.; Hoi Sang, U.; Yoshida, Kazunari; Gage, F. H.

In: Annals of Neurology, Vol. 30, No. 5, 1991, p. 625-636.

Research output: Contribution to journalArticle

@article{5bb6412b1d6e43e79ac4f7c17a73c661,
title = "Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain",
abstract = "Atrophy of cholinergic neurons is a prominent component of Alzheimer's disease, and may explain in part the profound memory loss that is characteristic of patients with this disorder. Previous studies in animal models have shown that infusions of nerve growth factor into the adult brain can prevent both age-related and lesion-induced cholinergic neuronal atrophy. Recently, recombinant human nerve growth factor was found biologically active in nonprimate animal models. In the present experiment, recombinant human nerve growth factor infusions into the brains of adult primates prevented lesion-induced cholinergic neuronal degeneration and promoted cholinergic neurite sprouting. These findings provide additional support for potential therapeutic trials of human nerve growth factor in patients with Alzheimer's disease.",
author = "Tuszynski, {M. H.} and {Hoi Sang}, U. and Kazunari Yoshida and Gage, {F. H.}",
year = "1991",
language = "English",
volume = "30",
pages = "625--636",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain

AU - Tuszynski, M. H.

AU - Hoi Sang, U.

AU - Yoshida, Kazunari

AU - Gage, F. H.

PY - 1991

Y1 - 1991

N2 - Atrophy of cholinergic neurons is a prominent component of Alzheimer's disease, and may explain in part the profound memory loss that is characteristic of patients with this disorder. Previous studies in animal models have shown that infusions of nerve growth factor into the adult brain can prevent both age-related and lesion-induced cholinergic neuronal atrophy. Recently, recombinant human nerve growth factor was found biologically active in nonprimate animal models. In the present experiment, recombinant human nerve growth factor infusions into the brains of adult primates prevented lesion-induced cholinergic neuronal degeneration and promoted cholinergic neurite sprouting. These findings provide additional support for potential therapeutic trials of human nerve growth factor in patients with Alzheimer's disease.

AB - Atrophy of cholinergic neurons is a prominent component of Alzheimer's disease, and may explain in part the profound memory loss that is characteristic of patients with this disorder. Previous studies in animal models have shown that infusions of nerve growth factor into the adult brain can prevent both age-related and lesion-induced cholinergic neuronal atrophy. Recently, recombinant human nerve growth factor was found biologically active in nonprimate animal models. In the present experiment, recombinant human nerve growth factor infusions into the brains of adult primates prevented lesion-induced cholinergic neuronal degeneration and promoted cholinergic neurite sprouting. These findings provide additional support for potential therapeutic trials of human nerve growth factor in patients with Alzheimer's disease.

UR - http://www.scopus.com/inward/record.url?scp=0026008812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026008812&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 625

EP - 636

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 5

ER -